{"id":4811,"date":"2026-03-27T16:00:03","date_gmt":"2026-03-27T14:00:03","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=4811"},"modified":"2026-10-30T13:29:41","modified_gmt":"2026-10-30T11:29:41","slug":"%cf%83%cf%85%ce%bc%ce%bc%ce%b5%cf%84%ce%bf%cf%87%ce%b7-%cf%84%ce%b7%cf%83-iasis-pharma-24%ce%bf-%cf%80%ce%b1%ce%bd%ce%b5%ce%bb%ce%bb%ce%b7%ce%bd%ce%b9%ce%bf-%ce%b4%ce%b9%ce%b1%ce%b2%ce%b7%cf%84","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/%cf%83%cf%85%ce%bc%ce%bc%ce%b5%cf%84%ce%bf%cf%87%ce%b7-%cf%84%ce%b7%cf%83-iasis-pharma-24%ce%bf-%cf%80%ce%b1%ce%bd%ce%b5%ce%bb%ce%bb%ce%b7%ce%bd%ce%b9%ce%bf-%ce%b4%ce%b9%ce%b1%ce%b2%ce%b7%cf%84\/","title":{"rendered":"PARTICIPATION OF IASIS PHARMA IN THE \u201c24th PANHELLENIC DIABETES CONGRESS\u201d"},"content":{"rendered":"<p><strong>18 \u2013 21\/03\/2026<\/strong><\/p>\n<p><strong>Divani Caravel Hotel, Athens.<\/strong><\/p>\n<p><strong>IASIS PHARMA<\/strong>\u00a0participated at the\u00a0<strong>\u201c24th PANHELLENIC DIABETES CONGRESS\u201d<\/strong>, held in Athens, at the\u00a0<strong>Divani Caravel Hotel<\/strong>, showing its active interest in Diabetes Mellitus disease. Moreover,\u00a0<strong>IASIS PHARMA<\/strong>\u00a0is about to invest significantly in T2DM by\u00a0<strong>launching original products in oral liquid forms<\/strong>.<\/p>\n<p>The conference took place from\u00a0<strong>March 18\u00a0<\/strong>to<strong>\u00a021, 2026<\/strong>, with the participation of more than 1.500 Health Care Professionals.<\/p>\n<p><strong>IASIS PHARMA<\/strong>\u00a0participated in the event with an exhibition stand, where experts had the opportunity to visit and learn about the range of high-quality proprietary pharmaceuticals available from the company.<\/p>\n<p>At\u00a0<strong>IASIS PHARMA exhibition stand<\/strong>, the following products were presented:<\/p>\n<ul>\n<li><strong>RosuZet<sup>\u00ae<\/sup><\/strong>: Fixed-dose combination of\u00a0<strong>Rosuvastatin &amp; Ezetimibe<\/strong>, in a single dosage form, in packages of\u00a0 30 f.c. tabs available in the full spectrum of strengths: (Rosuvastatin \/ Ezetimibe) 5 \/ 10mg, 10 \/ 10mg, 20 \/ 10mg, 40 \/ 10mg.<\/li>\n<li><strong>Rami\u2013Amlo<sup>\u00ae<\/sup>:\u00a0<\/strong>a fixed-dose combination of\u00a0<strong>Ramipril &amp; Amlodipine<\/strong>\u00a0in a single dosage form, in packages of 28 capsules, available in 4 strengths: (Ramipril \/ Amlodipine) 5mg \/ 5mg, \u00a05mg \/ 10mg, 10mg \/ 5mg, 10mg \/ 10mg.<\/li>\n<li><strong>Rami\u2013Amlo\u00a0plus<sup>\u00ae<\/sup>:\u00a0<\/strong>also an original fixed-dose combination of\u00a0<strong>Ramipril \u2013 Amlodipine \u2013Hydrochlorothiazide<\/strong>, which is available in packages of 30 capsules, in a wide range of strengths: (Ramipril \/ Amlodipine \/ Hydrochlorothiazide) 5 mg \/ 5 mg \/ 12,5 mg, 5 mg \/ 5 mg \/ 25 mg, 10 mg \/ 5 mg \/ 25 mg, 10 mg \/ 10 mg \/ 25 mg.<\/li>\n<li><strong>&#8211; Glucofree<sup>\u00ae<\/sup>: <\/strong>Each film-coated tablet contains\u00a0<strong>850 mg Metformin hydrochloride<\/strong>, equivalent to 662,9 mg metformin respectively (box of\u00a0<strong>60<\/strong>\u00a0f.c. tabs).<strong><br \/>\n<\/strong>&#8211;\u00a0\u00a0<strong>Glucoplus<sup>\u00ae<\/sup>:\u00a0<\/strong>Each film-coated tablet contains\u00a0<strong>1000 mg Metformin hydrochloride<\/strong>, equivalent to 780mg Metformin respectively (box of\u00a0<strong>60<\/strong>\u00a0f.c. tabs).<\/li>\n<li><strong>MAG-IASIS<sup>\u00ae<\/sup>:\u00a0<\/strong>the first uniquely effective combination of 1193.57 mg Magnesium\u00a0<strong>citrate<\/strong>\u00a0&amp; 667.56 mg Magnesium\u00a0<strong>aspartate<\/strong>, equivalent to\u00a0<strong>243 mg Magnesium<\/strong>, indicated for magnesium deficiency, in the form of\u00a0<strong>40 effervescent tablets<\/strong>.<\/li>\n<\/ul>\n<p><img decoding=\"async\" class=\"alignleft size-full wp-image-4803\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/03\/synedrio-1-copy.png\" alt=\"\" width=\"650\" height=\"524\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/03\/synedrio-1-copy-120x97.png 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/03\/synedrio-1-copy-177x142.png 177w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/03\/synedrio-1-copy-200x161.png 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/03\/synedrio-1-copy-300x242.png 300w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/03\/synedrio-1-copy-400x322.png 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/03\/synedrio-1-copy-500x403.png 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/03\/synedrio-1-copy-600x484.png 600w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/03\/synedrio-1-copy.png 650w\" sizes=\"(max-width: 650px) 100vw, 650px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>18 \u2013 21\/03\/2026 Divani Caravel Hotel, Athens. IASIS PHARMA\u00a0participated at the\u00a0\u201c24th PANHELLENIC DIABETES CONGRESS\u201d, held in Athens, at the\u00a0Divani Caravel Hotel, showing its active interest in Diabetes Mellitus disease. Moreover,\u00a0IASIS PHARMA\u00a0is about to invest significantly in T2DM by\u00a0launching original products in oral liquid forms. The conference took place from\u00a0March 18\u00a0to\u00a021, 2026, with the participation of  [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,157,204],"tags":[],"class_list":["post-4811","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-press-room-en","category-conferences"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-1fB","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=4811"}],"version-history":[{"count":3,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4811\/revisions"}],"predecessor-version":[{"id":4814,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4811\/revisions\/4814"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=4811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=4811"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=4811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}